These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11922958)

  • 1. Bisphosphonates and atherosclerosis.
    Ylitalo R
    Gen Pharmacol; 2000 Dec; 35(6):287-96. PubMed ID: 11922958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates and atherosclerosis: why?
    Bevilacqua M; Dominguez LJ; Rosini S; Barbagallo M
    Lupus; 2005; 14(9):773-9. PubMed ID: 16218486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liposome-encapsulated bisphosphonates on acetylated LDL metabolism, lipid accumulation and viability of phagocyting cells.
    Ylitalo R; Mönkkönen J; Ylä-Herttuala S
    Life Sci; 1998; 62(5):413-22. PubMed ID: 9449231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
    Ylitalo R; Kalliovalkama J; Wu X; Kankaanranta H; Salenius JP; Sisto T; Lähteenmäki T; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 1998 Sep; 83(3):125-31. PubMed ID: 9783331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of calcification by bisphosphonates].
    Ono K; Wada S
    Clin Calcium; 2004 Jun; 14(6):60-3. PubMed ID: 15577056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of viability and acetyl-LDL metabolism in RAW 264 macrophage-like and smooth muscle cells by bisphosphonates in vitro.
    Tuominen OM; Hollmén M; Jaakkola O; Mönkkönen J; Ylitalo R
    Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):487-92. PubMed ID: 12500427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New bisphosphonates in osteoporosis.
    Fleisch H
    Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Lomashvili KA; Monier-Faugere MC; Wang X; Malluche HH; O'Neill WC
    Kidney Int; 2009 Mar; 75(6):617-25. PubMed ID: 19129793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
    Licata AA
    Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherosclerosis and bisphosphonate].
    Shioi A
    Clin Calcium; 2003 Feb; 13(2):169-72. PubMed ID: 15775079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with bisphosphonates.
    Lombardi A; Santora AC
    Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonates for vascular calcification].
    Tanaka Y; Okada Y
    Clin Calcium; 2007 Mar; 17(3):386-90. PubMed ID: 17339743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
    Mönkkönen J; Taskinen M; Auriola SO; Urtti A
    J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of immunoreactive macrophages in atheromatous lesions of rabbits by clodronate.
    Ylitalo R; Syvälä H; Tuohimaa P; Ylitalo P
    Pharmacol Toxicol; 2002 Mar; 90(3):139-43. PubMed ID: 12071335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.